Evidence map›Paper›PMID 39444727›Full record

ReviewRevista cientifica odontologica (Universidad Cientifica del Sur)

[Molecular basis of ameloblastoma pathogenesis: A review].

Grecia Lourdes Riofrio Chung, Tania Lisseth Santos Tucto, Angela Quispe-Salcedo

Abstract readEnglish AbstractReview
In one paragraph

Review in Revista cientifica odontologica (Universidad Cientifica del Sur). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Grecia Lourdes Riofrio ChungFacultad de Odontología, Universidad Nacional Mayor de San Marcos. Lima, Perú. grecia.riofrio.06@gmail.com Universidad Nacional Mayor de San Marcos Facultad de Odontología Universidad Nacional Mayor de San Marcos Lima Peru grecia.riofrio.06@gmail.com.ORCID https://orcid.org/0000-0002-3343-6228
Tania Lisseth Santos TuctoFacultad de Medicina, Universidad Científica del Sur. Lima, Perú. tsantos@cientifica.edu.pe Universidad Científica del Sur Facultad de Medicina Universidad Científica del Sur Lima Peru tsantos@cientifica.edu.pe.ORCID https://orcid.org/0000-0002-2585-1499
Angela Quispe-SalcedoDivision of Anatomy and Cell Biology of the Hard Tissue. Niigata University Graduate School of Medical and Dental Science. Niigata, Japón.aquispesa@dent.niigata-u.ac.jp Niigata University Division of Anatomy and Cell Biology of the Hard Tissue Niigata University Graduate School of Medical and Dental Science Niigata Japan aquispesa@dent.niigata-u.ac.jp.ORCID https://orcid.org/0000-0002-6449-4631

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ameloblastoma is the most common and highly invasive benign odontogenic tumor. Its pathogenesis is not yet fully understood. Objective: To describe the most important molecular findings that promote the proliferative activity of ameloblastoma and the factors involved that encourage invasion into surrounding bone tissues. Methodology: A search for scientific evidence was conducted through the following databases: Science Direct, Medline, Wiley, Web of Science, and Google Scholar. A total of 32 articles were reviewed, with inclusion criteria being articles published in English and Spanish; descriptive and analytical studies, narrative and systematic reviews published from January 2015 to June 2021. Letters to the editor were excluded. Results: The biological molecular findings that allow ameloblastoma to invade surrounding tissues involve alterations in the RANK/RANKL/OPG pathways, transforming growth factor beta (TGF-β), Wnt/β-catenin pathway, and matrix metalloproteinases, as well as alterations in MAPK and SHH pathways that facilitate the proliferation and tumor development of ameloblastoma. Conclusions: These findings are fundamental for a better understanding of the pathways involved in the pathogenesis of ameloblastoma.

Indexed as

ameloblastomabone resorptionMAP kinase signaling systemmolecular biologySHH protein human

Identifiers

PMID39444727
PMCPMC11495173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.